Johnson & Johnson vaccine much less effective against delta variant, new study says

CNBC Television published this video item, entitled “Johnson & Johnson vaccine much less effective against delta variant, new study says” – below is their description.

An NYU lab study suggests that one dose of the Johnson & Johnson vaccine is significantly less effective against the delta variant. The study confirms that Moderna and Pfizer’s covid vaccines are still effective against the delta strain.

CNBC Television YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

About This Source - CNBC Television

CNBC is an American pay television business news channel, which primarily carries business day coverage of U.S. and international financial markets. Following the end of the business day and on non-trading days, CNBC primarily carries financial and business-themed documentaries and reality shows.

As of February 2015, CNBC is available to approximately 93,623,000 pay television households (80.4% of households with television) in the United States.

Recent from CNBC Television:

  • Former FDIC Chair Sheila Bair is teaching children about money
  • 13,000 Haitian migrants cross into Texas
  • Security very tight around U.S. Capitol ahead of far-right rally
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • IN FULL: ACT records seven new locally acquired cases of COVID-19 | ABC News
  • IN FULL: Victorian records 567 new cases of COVID-19 | ABC News
  • NSW records a dip in COVID cases, but 4 new deaths | 7NEWS
  • NSW records 935 new cases, Modelling predicts Victoria’s cases could soar | 9 News Australia
  • IN FULL: NSW records 935 COVID-19 cases, four deaths | ABC News
  • In This Story: Moderna

    Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

    CEO: Stéphane Bancel (2011–)

    Stock ticker: (NASDAQ:MRNA)

    5 Recent Items: Moderna

  • COVID-19 20 Sep | Victoria roadmap, Sydney restrictions loosen, learning from Singapore | ABC News
  • Australia’s Moderna COVID Vaccine boost | 1 million doses arrive | 7NEWS
  • Australian COVID Update | Path to lockdown freedom opens up | 7NEWS
  • Fauci: Data For Moderna, Johnson & Johnson Booster Shots Is ‘A Few weeks’ Out
  • Moderna COVID vaccine shipment about to arrive in Sydney | 7NEWS
  • In This Story: Pfizer

    Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical corporation headquartered in New York City. In 2012, it was one of the world’s largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

    5 Recent Items: Pfizer

  • Should Queensland get drive-through vaccine clinics? | 7NEWS
  • Nightly News Full Broadcast (September 18th)
  • Queensland’s Super Pfizer Weekend continues | 7NEWS
  • Queenslanders take their shot at full vaccination amid new vaccine blitz | 7NEWS
  • Vaccine rollout for kids explained, Update to national reopening plan | 9 News Australia
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.